Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
THRX > SEC Filings for THRX > Form 8-K on 26-Mar-2013All Recent SEC Filings

Show all filings for THERAVANCE INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for THERAVANCE INC


26-Mar-2013

Regulation FD Disclosure


Item 7.01 Regulation FD Disclosure.

The information contained in this Item 7.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Securities Exchange Act of 1934"), or incorporated by reference in any filing under the Securities Exchange Act of 1934 or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

GlaxoSmithKline plc (GSK) is scheduled to present data from Phase 1 and Phase 3 studies of umeclidinium/vilanterol (UMEC/VI), with proposed brand name of ANORO™ at the American Thoracic Society (ATS) International Conference held in Philadelphia, Pennsylvania from May 17-22, 2013. In addition, GSK is scheduled to present data from Phase 3 studies of fluticasone furoate/vilanterol (FF/VI), with proposed brand names of RELVAR™ and BREO™, at ATS. UMEC/VI is a combination of two investigational bronchodilator molecules - GSK573719 or UMEC, a long-acting muscarinic antagonist and VI, a long-acting beta2 agonist (LABA) for the treatment of chronic obstructive pulmonary disease (COPD). FF/VI is an investigational once-daily inhaled corticosteroid/LABA combination treatment for the maintenance treatment of patients with COPD and patients with asthma. FF/VI and UMEC/VI are in development under the LABA collaboration between GSK and Theravance, Inc. Titles of the posters and presentations can be found on the ATS conference website.


  Add THRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for THRX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.